Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 24:11:682470.
doi: 10.3389/fonc.2021.682470. eCollection 2021.

Follicle Rescue From Prepubertal Ovaries After Recent Treatment With Cyclophosphamide-An Experimental Culture System Using Mice to Achieve Mature Oocytes for Fertility Preservation

Affiliations

Follicle Rescue From Prepubertal Ovaries After Recent Treatment With Cyclophosphamide-An Experimental Culture System Using Mice to Achieve Mature Oocytes for Fertility Preservation

Xia Hao et al. Front Oncol. .

Abstract

Ovarian tissue cryopreservation is the only feasible method for fertility preservation in prepubertal girls that will undergo gonadotoxic chemotherapy. To date, the only clinical use of cryopreserved tissue is by a later tissue retransplantation to the patient. Clinical challenges in fertility preservation of very young patients with cancer include time constraints that do not allow to retrieve the tissue for cryopreservation before starting chemotherapy and the preclusion of future ovarian tissue transplantation due to the risk of reintroduction of malignant cells in patients with systemic diseases. To overcome these two challenges, we investigated using an experimental model the feasibility of retrieving secondary follicles from ovaries of prepubertal mice after cyclophosphamide (CPA) treatment in increasing doses of 50, 75, and 100 mg/kg. The follicles were thereafter cultured and matured in vitro. The main outcomes included the efficiency of the method in terms of obtained matured oocytes and the safety of these potentially fertility preservative procedures in terms of analyses of oocyte competence regarding normality of the spindle and chromosome configurations. Our findings demonstrated that it was feasible to isolate and culture secondary follicles and to obtain mature oocytes from prepubertal mice ovaries recently treated with CPA. The efficiency of this method was highly demonstrated in the 100 mg/kg CPA group, with near 90% follicle survival rate after 12 days' culture, similarly to control. Around 80% of the follicles met the criteria to put into maturation, and more than 40% of them achieved metaphase II, with normal spindle and chromosome configurations observed. Suboptimal results were obtained in the 50 and 75 mg/kg CPA groups. These paradoxical findings towards CPA dose might probably reflect a more difficult selection of damaged growing follicles from ovaries recently treated with lower doses of CPA and a hampered ability to identify and discard those with reduced viability for the culture.

Keywords: chemotherapy; cyclophosphamide; female fertility preservation; in vitro culture and maturation; ovarian follicle isolation; prepubertal ovary.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Follicular growth curve in each group during the culture (X, culture days; Y, mean follicular diameter, µm).
Figure 2
Figure 2
(A) 17β-estradiol and (B) AMH secreted by individual follicle into the culture medium during the culture.
Figure 3
Figure 3
Representative figures of spindle and chromosome configurations in MII oocytes from each group. Spindle fibers were detected by immunofluorescence for α-tubulin (green), while DNA was stained with propidium iodide (red). Scale bar, 10 µm.

Similar articles

References

    1. Grady MC. Preconception and the Young Cancer Survivor . Maternal Child Health J (2006) 10(5 Suppl):S165–8. doi: 10.1007/s10995-006-0103-1 - DOI - PMC - PubMed
    1. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. . Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol (2018) 36(19):1994–2001. doi: 10.1200/JCO.2018.78.1914 - DOI - PubMed
    1. ESHRE Guideline Group on Female Fertility Preservation. Anderson RA, Amant F, Braat D, D'Angelo A, Chuva de Sousa Lopes SM, et al. . ESHRE Guideline: Female Fertility Preservation. Hum Reprod Open (2020) 2020(4):hoaa052. doi: 10.1093/hropen/hoaa052 - DOI - PMC - PubMed
    1. Rodriguez-Wallberg KA, Oktay K. Fertility Preservation Medicine: Options for Young Adults and Children With Cancer. J Pediatr Hematol Oncol (2010) 32(5):390–6. doi: 10.1097/MPH.0b013e3181dce339 - DOI - PubMed
    1. Rodriguez-Wallberg KA, Marklund A, Lundberg F, Wikander I, Milenkovic M, Anastacio A, et al. . A Prospective Study of Women and Girls Undergoing Fertility Preservation Due to Oncologic and non-Oncologic Indications in Sweden-Trends in Patients’ Choices and Benefit of the Chosen Methods After Long-Term Follow Up. Acta Obstet Gynecol Scand (2019) 98(5):604–15. doi: 10.1111/aogs.13559 - DOI - PubMed